The tumor volume and weight of the FSCN1-OE group were significantly larger than those of the control group, whereas they were substantially smaller in the PTK6-T2 group (Figure 6J), suggesting that FSCN1 promotes EC growth by inhibiting PTK6. The gene discussed is FSCN1; the disease is neoplasm.